2002
DOI: 10.1590/s0004-27302002000400006
|View full text |Cite
|
Sign up to set email alerts
|

Entendendo o Processo Molecular da Tumorigênese

Abstract: RESUMONos últimos 25 anos, o reconhecimento dos mecanismos genético-moleculares implicados na gênese e na progressão do câncer tem permitido obter novos métodos de diagnóstico e de acompanhamento, redirecionando de forma drástica a terapêutica do paciente com neoplasia. Alguns marcadores moleculares já estão sendo utilizados na rotina e deverão prover testes sensíveis e específicos para o diagnóstico precoce, estadiamento e acompanhamento do paciente com câncer. As características moleculares de cada tumor dev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0
20

Year Published

2010
2010
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(28 citation statements)
references
References 36 publications
0
8
0
20
Order By: Relevance
“…58 It is believed that, in the future, gene therapy will make it possible to treat mutations that cause TSC through reintroduction of defective genes, leading to induction of apoptosis of mutated cells, or through reintroduction of the lost gene, enabling the cell to present normal phenotype and avoiding the clinical changes of TSC. 59 Although associated with frequent systemic complications, the dermatologist plays an essential role in the diagnosis and monitoring of these patients; d. Diagnosis of the disease is subject to clinical criteria, and advances in genetics and molecular biology have contributed little to the diagnosis and treatment of these patients.…”
Section: Figure 11mentioning
confidence: 99%
“…58 It is believed that, in the future, gene therapy will make it possible to treat mutations that cause TSC through reintroduction of defective genes, leading to induction of apoptosis of mutated cells, or through reintroduction of the lost gene, enabling the cell to present normal phenotype and avoiding the clinical changes of TSC. 59 Although associated with frequent systemic complications, the dermatologist plays an essential role in the diagnosis and monitoring of these patients; d. Diagnosis of the disease is subject to clinical criteria, and advances in genetics and molecular biology have contributed little to the diagnosis and treatment of these patients.…”
Section: Figure 11mentioning
confidence: 99%
“…Esses agentes promotores podem interferir no processo de diferenciação celular, que ocorre quando as células passam de população de células pluripotentes para células funcionantes (Ward, 2002).…”
Section: Amo Muito Vocêsunclassified
“…Os tumores benignos podem se originar em qualquer tecido e não apresentam caráter invasivo, limitando-se ao local onde se originaram, podendo causar a obstrução ou pressão local devido ao volume da massa tumoral (Franks e Teich, 1990;Ward, 2002).…”
Section: Amo Muito Vocêsunclassified
See 2 more Smart Citations